ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million
Go back to ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 80.58 +1.09 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.49 | 52 Week High | $70.92 | |||
| Open | $79.57 | 52 Week Low | $26.80 | |||
| Day High | $82.15 | P/E | N/A | |||
| Day Low | $78.84 | EPS | $-0.96 | |||
| Volume | 477,460 | |||||
